Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
A meta-analysis published in Current Biology suggests men who get fewer than six hours of sleep a night leading up to a vaccination had a weaker antibody response compared to those who got more sleep.
At its annual health event on Tuesday, Google announced a series of changes to its search tool that it said will make it easier to access information about affordable health care services.
The Environmental Protection Agency (EPA) is proposing the nation's first-ever drinking water standard around polyfluoroalkyl substances (PFAS) or "forever chemicals."
A new atmospheric river brought heavy rain, thunderstorms and strong winds to California on Friday, raising the threat of flooding and disrupting travel.
